A young mother who reported to his pharmacist presence of a piece of glass in a bottle Oracefal ® 250 mg / 5 ml powder for oral suspension, a procedure recall this product has been triggered. Oracefal ® is an antibiotic used against infections of the respiratory tract and ENT infections in children. The pharmaceutical company Bristol-Myers Squibb, in agreement with the French Agency for Sanitary Safety of Health Products (AFSSAPS) has decided to initiate a recall of Lot 9J56684 (expiry 09/2012).
. The drug Oracefal ® 250 mg / 5 ml powder is administered after reconstitution with water using a measuring spoon. The manufacturer has informed that the suspect lot AFSSaPS was not distributed to pharmacies since January 25, 2010. No other claim of the same type was received by the laboratory.
AFSSaPS The recommended "for patients in possession of a bottle bearing the lot number does not use it and report it to the pharmacy." The agency also requests the laboratory "to identify the causes that led to the presence of the piece of glass found in bottle of that lot." Bristol-Myers Squibb in June, had already had to make the recall of a batch of vials of Fungizone (R) 10% ... for the same reasons.
http://www.destinationsante.com/Alerte-sante-des-morceaux-de-verre-dans-un-sirop.html
0 comments:
Post a Comment